Farms.com Home   Ag Industry News

Dairy farm kids less likely to develop allergies, study

Children and pregnant women may benefit from spending time on dairy farms

By Amanda Brodhagen, Farms.com

Youngsters who live on dairy farms are less susceptible to develop allergies. According to a study published in The Journal of Immunology, conducted by researchers at The University of Gothenburg in Sweden, children are not the only ones who can benefit from being around a dairy farm, but pregnant women too.

Scientists found that children who grow up on dairy farms run a much lower risk of having allergies compared to other children. Farm kids are about one-tenth at risk of developing allergies. And for pregnant women, spending time on dairy farms can help promote maturation of the fetal and neonatal immune system.

The study notes that children that are less exposed to microorganisms are found to have fewer infections.

One of the researchers, Anna-Carin Lundell, said “our study also demonstrated for the first time that delayed maturation of the immune system, specifically B-cells, is a risk factor for development of allergies.”

More studies are needed to verify the link between delayed B-cell maturation and the period of risk that follow the development of allergies.

“We need to identify the specific factors on dairy farms that strengthen protection against allergies and appear to promote maturation of the immune system as early as the fetal stage,” said Lundell.

The study was conducted on rural children that lived in the areas of Västra Götaland Region, and half of the participants in the study were from dairy farms.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.